APO Research

APO RESEARCH · REPORT

Exoglucanase

Selected research

Industry Growth & Trends

Global Exoglucanase Industry Growth and Trends Forecast to 2032

Market perspective

The global Exoglucanase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Exoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Exoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Exoglucanase include Mitsubishi Chemical, DuPont, BASF, Ultreze, Sunson Industry, Specialty Enzymes & Probiotics, Novozymes, KeyGene and Infinita Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Exoglucanase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Exoglucanase market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exoglucanase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exoglucanase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Exoglucanase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Exoglucanase Market by Company

Mitsubishi Chemical

DuPont

BASF

Ultreze

Sunson Industry

Specialty Enzymes & Probiotics

Novozymes

KeyGene

Infinita Biotech

ENMEX

DuPont Industrial Biosciences

DSM

BIO-CAT

Amano Enzyme

AB Enzymes

Exoglucanase Segment by Type

Cutting to the Reduction End

Cutting to the Non-Reduction End

Exoglucanase Segment by Application

Food and Brewing Industry

Biomedical Material Synthesis

Lignocellulose Conversion

Extreme Environment Bioprocessing

Other

Exoglucanase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoglucanase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exoglucanase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoglucanase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Exoglucanase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Exoglucanase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cutting to the Reduction End Table 2. Major Company of Cutting to the Non-Reduction End Table 3. Global Exoglucanase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Exoglucanase Sales by Type (2021-2026) & (t) Table 5. Global Exoglucanase Sales Market Share in Volume by Type (2021-2026) Table 6. Global Exoglucanase Sales by Type (2021-2026) & (US$ Million) Table 7. Global Exoglucanase Sales Market Share in Value by Type (2021-2026) Table 8. Global Exoglucanase Price by Type (2021-2026) & (USD/kg) Table 9. Global Exoglucanase Sales by Type (2027-2032) & (t) Table 10. Global Exoglucanase Sales Market Share in Volume by Type (2027-2032) Table 11. Global Exoglucanase Sales by Type (2027-2032) & (US$ Million) Table 12. Global Exoglucanase Sales Market Share in Value by Type (2027-2032) Table 13. Global Exoglucanase Price by Type (2027-2032) & (USD/kg) Table 14. North America Exoglucanase Sales by Type (2021-2026) & (t) Table 15. North America Exoglucanase Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Exoglucanase Sales by Type (2021-2026) & (t) Table 17. Europe Exoglucanase Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Exoglucanase Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Exoglucanase Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Exoglucanase Sales by Type (2021-2026) & (t) Table 21. Latin America Exoglucanase Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Exoglucanase Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Exoglucanase Sales by Type (2021-2026) & (US$ Million) Table 24. Exoglucanase Industry Trends Table 25. Exoglucanase Industry Drivers Table 26. Exoglucanase Industry Opportunities and Challenges Table 27. Exoglucanase Industry Restraints Table 28. Global Exoglucanase Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Exoglucanase Revenue Market Share by Company (2021-2026) Table 30. Global Exoglucanase Sales by Company (2021-2026) & (t) Table 31. Global Exoglucanase Sales Share by Company (2021-2026) Table 32. Global Exoglucanase Market Price by Company (2021-2026) & (USD/kg) Table 33. Global Exoglucanase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Exoglucanase Major Company Production Sites and Headquarters Table 35. Global Exoglucanase Company, Product Type & Application Table 36. Global Exoglucanase Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Exoglucanase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Exoglucanase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Exoglucanase Sales by Region (2021-2026) & (t) Table 41. Global Exoglucanase Sales Market Share in Volume by Region (2021-2026) Table 42. Global Exoglucanase Sales by Region (2021-2026) & (US$ Million) Table 43. Global Exoglucanase Sales Market Share in Value by Region (2021-2026) Table 44. Global Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global Exoglucanase Sales by Region (2027-2032) & (t) Table 46. Global Exoglucanase Sales Market Share in Volume by Region (2027-2032) Table 47. Global Exoglucanase Sales by Region (2027-2032) & (US$ Million) Table 48. Global Exoglucanase Sales Market Share in Value by Region (2027-2032) Table 49. Global Exoglucanase Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global Exoglucanase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Exoglucanase Sales by Application (2021-2026) & (t) Table 52. Global Exoglucanase Sales Market Share in Volume by Application (2021-2026) Table 53. Global Exoglucanase Sales by Application (2021-2026) & (US$ Million) Table 54. Global Exoglucanase Sales Market Share in Value by Application (2021-2026) Table 55. Global Exoglucanase Price by Application (2021-2026) & (USD/kg) Table 56. Global Exoglucanase Sales by Application (2027-2032) & (t) Table 57. Global Exoglucanase Sales Market Share in Volume by Application (2027-2032) Table 58. Global Exoglucanase Sales by Application (2027-2032) & (US$ Million) Table 59. Global Exoglucanase Sales Market Share in Value by Application (2027-2032) Table 60. Global Exoglucanase Price by Application (2027-2032) & (USD/kg) Table 61. North America Exoglucanase Sales by Application (2021-2026) & (t) Table 62. North America Exoglucanase Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Exoglucanase Sales by Application (2021-2026) & (t) Table 64. Europe Exoglucanase Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Exoglucanase Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Exoglucanase Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Exoglucanase Sales by Application (2021-2026) & (t) Table 68. Latin America Exoglucanase Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Exoglucanase Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Exoglucanase Sales by Application (2021-2026) & (US$ Million) Table 71. Mitsubishi Chemical Company Information Table 72. Mitsubishi Chemical Business Overview Table 73. Mitsubishi Chemical Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. Mitsubishi Chemical Exoglucanase Product Portfolio Table 75. Mitsubishi Chemical Recent Development Table 76. DuPont Company Information Table 77. DuPont Business Overview Table 78. DuPont Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. DuPont Exoglucanase Product Portfolio Table 80. DuPont Recent Development Table 81. BASF Company Information Table 82. BASF Business Overview Table 83. BASF Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. BASF Exoglucanase Product Portfolio Table 85. BASF Recent Development Table 86. Ultreze Company Information Table 87. Ultreze Business Overview Table 88. Ultreze Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Ultreze Exoglucanase Product Portfolio Table 90. Ultreze Recent Development Table 91. Sunson Industry Company Information Table 92. Sunson Industry Business Overview Table 93. Sunson Industry Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Sunson Industry Exoglucanase Product Portfolio Table 95. Sunson Industry Recent Development Table 96. Specialty Enzymes & Probiotics Company Information Table 97. Specialty Enzymes & Probiotics Business Overview Table 98. Specialty Enzymes & Probiotics Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Specialty Enzymes & Probiotics Exoglucanase Product Portfolio Table 100. Specialty Enzymes & Probiotics Recent Development Table 101. Novozymes Company Information Table 102. Novozymes Business Overview Table 103. Novozymes Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. Novozymes Exoglucanase Product Portfolio Table 105. Novozymes Recent Development Table 106. KeyGene Company Information Table 107. KeyGene Business Overview Table 108. KeyGene Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. KeyGene Exoglucanase Product Portfolio Table 110. KeyGene Recent Development Table 111. Infinita Biotech Company Information Table 112. Infinita Biotech Business Overview Table 113. Infinita Biotech Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Infinita Biotech Exoglucanase Product Portfolio Table 115. Infinita Biotech Recent Development Table 116. ENMEX Company Information Table 117. ENMEX Business Overview Table 118. ENMEX Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 119. ENMEX Exoglucanase Product Portfolio Table 120. ENMEX Recent Development Table 121. DuPont Industrial Biosciences Company Information Table 122. DuPont Industrial Biosciences Business Overview Table 123. DuPont Industrial Biosciences Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 124. DuPont Industrial Biosciences Exoglucanase Product Portfolio Table 125. DuPont Industrial Biosciences Recent Development Table 126. DSM Company Information Table 127. DSM Business Overview Table 128. DSM Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 129. DSM Exoglucanase Product Portfolio Table 130. DSM Recent Development Table 131. BIO-CAT Company Information Table 132. BIO-CAT Business Overview Table 133. BIO-CAT Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 134. BIO-CAT Exoglucanase Product Portfolio Table 135. BIO-CAT Recent Development Table 136. Amano Enzyme Company Information Table 137. Amano Enzyme Business Overview Table 138. Amano Enzyme Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 139. Amano Enzyme Exoglucanase Product Portfolio Table 140. Amano Enzyme Recent Development Table 141. AB Enzymes Company Information Table 142. AB Enzymes Business Overview Table 143. AB Enzymes Exoglucanase Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 144. AB Enzymes Exoglucanase Product Portfolio Table 145. AB Enzymes Recent Development Table 146. North America Exoglucanase Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 147. North America Exoglucanase Sales by Country (2021-2026) & (t) Table 148. North America Exoglucanase Sales Market Share by Country (2021-2026) Table 149. North America Exoglucanase Sales Forecast by Country (2027-2032) & (t) Table 150. North America Exoglucanase Sales Market Share Forecast by Country (2027-2032) Table 151. North America Exoglucanase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Exoglucanase Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Exoglucanase Market Share by Country (2021-2026) Table 154. North America Exoglucanase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Exoglucanase Market Share Forecast by Country (2027-2032) Table 156. Europe Exoglucanase Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 157. Europe Exoglucanase Sales by Country (2021-2026) & (t) Table 158. Europe Exoglucanase Sales Market Share by Country (2021-2026) Table 159. Europe Exoglucanase Sales Forecast by Country (2027-2032) & (t) Table 160. Europe Exoglucanase Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Exoglucanase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Exoglucanase Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Exoglucanase Market Share by Country (2021-2026) Table 164. Europe Exoglucanase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Exoglucanase Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Exoglucanase Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Exoglucanase Sales by Country (2021-2026) & (t) Table 168. Asia-Pacific Exoglucanase Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Exoglucanase Sales Forecast by Country (2027-2032) & (t) Table 170. Asia-Pacific Exoglucanase Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Exoglucanase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Exoglucanase Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Exoglucanase Market Share by Country (2021-2026) Table 174. Asia-Pacific Exoglucanase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Exoglucanase Market Share Forecast by Country (2027-2032) Table 176. Latin America Exoglucanase Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 177. Latin America Exoglucanase Sales by Country (2021-2026) & (t) Table 178. Latin America Exoglucanase Sales Market Share by Country (2021-2026) Table 179. Latin America Exoglucanase Sales Forecast by Country (2027-2032) & (t) Table 180. Latin America Exoglucanase Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Exoglucanase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Exoglucanase Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Exoglucanase Market Share by Country (2021-2026) Table 184. Latin America Exoglucanase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Exoglucanase Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Exoglucanase Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Exoglucanase Sales by Country (2021-2026) & (t) Table 188. Middle East and Africa Exoglucanase Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Exoglucanase Sales Forecast by Country (2027-2032) & (t) Table 190. Middle East and Africa Exoglucanase Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Exoglucanase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Exoglucanase Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Exoglucanase Market Share by Country (2021-2026) Table 194. Middle East and Africa Exoglucanase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Exoglucanase Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Exoglucanase Distributors List Table 199. Exoglucanase Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Exoglucanase Image Figure 2. Global Exoglucanase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exoglucanase Market Size (2021-2032) & (US$ Million) Figure 4. Global Exoglucanase Sales (2021-2032) & (t) Figure 5. Cutting to the Reduction End Image Figure 6. Global Cutting to the Reduction End Sales YoY Growth (2021-2032) & (t) Figure 7. Cutting to the Non-Reduction End Image Figure 8. Global Cutting to the Non-Reduction End Sales YoY Growth (2021-2032) & (t) Figure 9. Global Exoglucanase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Exoglucanase Market Share by Type 2025 VS 2032 Figure 11. North America Exoglucanase Sales Market Share in Volume by Type in 2025 Figure 12. North America Exoglucanase Sales Market Share in Value by Type in 2025 Figure 13. Europe Exoglucanase Sales Market Share in Volume by Type in 2025 Figure 14. Europe Exoglucanase Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Exoglucanase Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Exoglucanase Sales Market Share in Value by Type in 2025 Figure 17. Latin America Exoglucanase Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Exoglucanase Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Exoglucanase Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Exoglucanase Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Exoglucanase Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Food and Brewing Industry Image Figure 24. Global Food and Brewing Industry Sales YoY Growth (2021-2032) & (t) Figure 25. Biomedical Material Synthesis Image Figure 26. Global Biomedical Material Synthesis Sales YoY Growth (2021-2032) & (t) Figure 27. Lignocellulose Conversion Image Figure 28. Global Lignocellulose Conversion Sales YoY Growth (2021-2032) & (t) Figure 29. Extreme Environment Bioprocessing Image Figure 30. Global Extreme Environment Bioprocessing Sales YoY Growth (2021-2032) & (t) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (t) Figure 33. Global Exoglucanase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Exoglucanase Market Share by Application 2025 VS 2032 Figure 35. North America Exoglucanase Sales Market Share in Volume by Application in 2025 Figure 36. North America Exoglucanase Sales Market Share in Value by Application in 2025 Figure 37. Europe Exoglucanase Sales Market Share in Volume by Application in 2025 Figure 38. Europe Exoglucanase Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Exoglucanase Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Exoglucanase Sales Market Share in Value by Application in 2025 Figure 41. Latin America Exoglucanase Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Exoglucanase Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Exoglucanase Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Exoglucanase Sales Market Share in Value by Application in 2025 Figure 45. North America Exoglucanase Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. North America Exoglucanase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Exoglucanase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Exoglucanase Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Exoglucanase Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Europe Exoglucanase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Exoglucanase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Exoglucanase Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Exoglucanase Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Asia-Pacific Exoglucanase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Exoglucanase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Exoglucanase Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Exoglucanase Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Latin America Exoglucanase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Exoglucanase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Exoglucanase Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Exoglucanase Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Middle East and Africa Exoglucanase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Exoglucanase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Exoglucanase Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Exoglucanase Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Exoglucanase Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cutting to the Reduction End
  • Cutting to the Non-Reduction End
Applications
  • Food and Brewing Industry
  • Biomedical Material Synthesis
  • Lignocellulose Conversion
  • Extreme Environment Bioprocessing
  • Other
Companies covered
  • Mitsubishi Chemical
  • DuPont
  • BASF
  • Ultreze
  • Sunson Industry
  • Specialty Enzymes & Probiotics
  • Novozymes
  • KeyGene
  • Infinita Biotech
  • ENMEX
  • DuPont Industrial Biosciences
  • DSM
  • BIO-CAT
  • Amano Enzyme
  • AB Enzymes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Exoglucanase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Exoglucanase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Exoglucanase Market by Type
  6. 1.3.1 Cutting to the Reduction End
  7. 1.3.2 Cutting to the Non-Reduction End
  8. 1.4 Global Exoglucanase Market Size by Type
  9. 1.4.1 Global Exoglucanase Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Exoglucanase Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Exoglucanase Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Exoglucanase Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Exoglucanase Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Exoglucanase Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Exoglucanase Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Exoglucanase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Exoglucanase Industry Trends
  2. 2.2 Exoglucanase Industry Drivers
  3. 2.3 Exoglucanase Industry Opportunities and Challenges
  4. 2.4 Exoglucanase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Exoglucanase Revenue (2021-2026)
  2. 3.2 Global Top Players by Exoglucanase Sales (2021-2026)
  3. 3.3 Global Top Players by Exoglucanase Price (2021-2026)
  4. 3.4 Global Exoglucanase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Exoglucanase Major Company Production Sites & Headquarters
  6. 3.6 Global Exoglucanase Company, Product Type & Application
  7. 3.7 Global Exoglucanase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Exoglucanase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Exoglucanase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Exoglucanase Tier 1, Tier 2, and Tier 3
4 Exoglucanase Regional Status and Outlook
  1. 4.1 Global Exoglucanase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Exoglucanase Historic Market Size by Region
  3. 4.2.1 Global Exoglucanase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Exoglucanase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Exoglucanase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Exoglucanase Forecasted Market Size by Region
  7. 4.3.1 Global Exoglucanase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Exoglucanase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Exoglucanase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Exoglucanase by Application
  1. 5.1 Exoglucanase Market by Application
  2. 5.1.1 Food and Brewing Industry
  3. 5.1.2 Biomedical Material Synthesis
  4. 5.1.3 Lignocellulose Conversion
  5. 5.1.4 Extreme Environment Bioprocessing
  6. 5.1.5 Other
  7. 5.2 Global Exoglucanase Market Size by Application
  8. 5.2.1 Global Exoglucanase Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Exoglucanase Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Exoglucanase Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Exoglucanase Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Exoglucanase Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Exoglucanase Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Exoglucanase Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Exoglucanase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Mitsubishi Chemical
  2. 6.1.1 Mitsubishi Chemical Company Information
  3. 6.1.2 Mitsubishi Chemical Business Overview
  4. 6.1.3 Mitsubishi Chemical Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Mitsubishi Chemical Exoglucanase Product Portfolio
  6. 6.1.5 Mitsubishi Chemical Recent Developments
  7. 6.2 DuPont
  8. 6.2.1 DuPont Company Information
  9. 6.2.2 DuPont Business Overview
  10. 6.2.3 DuPont Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 DuPont Exoglucanase Product Portfolio
  12. 6.2.5 DuPont Recent Developments
  13. 6.3 BASF
  14. 6.3.1 BASF Company Information
  15. 6.3.2 BASF Business Overview
  16. 6.3.3 BASF Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BASF Exoglucanase Product Portfolio
  18. 6.3.5 BASF Recent Developments
  19. 6.4 Ultreze
  20. 6.4.1 Ultreze Company Information
  21. 6.4.2 Ultreze Business Overview
  22. 6.4.3 Ultreze Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ultreze Exoglucanase Product Portfolio
  24. 6.4.5 Ultreze Recent Developments
  25. 6.5 Sunson Industry
  26. 6.5.1 Sunson Industry Company Information
  27. 6.5.2 Sunson Industry Business Overview
  28. 6.5.3 Sunson Industry Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sunson Industry Exoglucanase Product Portfolio
  30. 6.5.5 Sunson Industry Recent Developments
  31. 6.6 Specialty Enzymes & Probiotics
  32. 6.6.1 Specialty Enzymes & Probiotics Company Information
  33. 6.6.2 Specialty Enzymes & Probiotics Business Overview
  34. 6.6.3 Specialty Enzymes & Probiotics Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Specialty Enzymes & Probiotics Exoglucanase Product Portfolio
  36. 6.6.5 Specialty Enzymes & Probiotics Recent Developments
  37. 6.7 Novozymes
  38. 6.7.1 Novozymes Company Information
  39. 6.7.2 Novozymes Business Overview
  40. 6.7.3 Novozymes Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novozymes Exoglucanase Product Portfolio
  42. 6.7.5 Novozymes Recent Developments
  43. 6.8 KeyGene
  44. 6.8.1 KeyGene Company Information
  45. 6.8.2 KeyGene Business Overview
  46. 6.8.3 KeyGene Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 KeyGene Exoglucanase Product Portfolio
  48. 6.8.5 KeyGene Recent Developments
  49. 6.9 Infinita Biotech
  50. 6.9.1 Infinita Biotech Company Information
  51. 6.9.2 Infinita Biotech Business Overview
  52. 6.9.3 Infinita Biotech Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Infinita Biotech Exoglucanase Product Portfolio
  54. 6.9.5 Infinita Biotech Recent Developments
  55. 6.10 ENMEX
  56. 6.10.1 ENMEX Company Information
  57. 6.10.2 ENMEX Business Overview
  58. 6.10.3 ENMEX Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 ENMEX Exoglucanase Product Portfolio
  60. 6.10.5 ENMEX Recent Developments
  61. 6.11 DuPont Industrial Biosciences
  62. 6.11.1 DuPont Industrial Biosciences Company Information
  63. 6.11.2 DuPont Industrial Biosciences Business Overview
  64. 6.11.3 DuPont Industrial Biosciences Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 DuPont Industrial Biosciences Exoglucanase Product Portfolio
  66. 6.11.5 DuPont Industrial Biosciences Recent Developments
  67. 6.12 DSM
  68. 6.12.1 DSM Company Information
  69. 6.12.2 DSM Business Overview
  70. 6.12.3 DSM Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 DSM Exoglucanase Product Portfolio
  72. 6.12.5 DSM Recent Developments
  73. 6.13 BIO-CAT
  74. 6.13.1 BIO-CAT Company Information
  75. 6.13.2 BIO-CAT Business Overview
  76. 6.13.3 BIO-CAT Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 BIO-CAT Exoglucanase Product Portfolio
  78. 6.13.5 BIO-CAT Recent Developments
  79. 6.14 Amano Enzyme
  80. 6.14.1 Amano Enzyme Company Information
  81. 6.14.2 Amano Enzyme Business Overview
  82. 6.14.3 Amano Enzyme Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Amano Enzyme Exoglucanase Product Portfolio
  84. 6.14.5 Amano Enzyme Recent Developments
  85. 6.15 AB Enzymes
  86. 6.15.1 AB Enzymes Company Information
  87. 6.15.2 AB Enzymes Business Overview
  88. 6.15.3 AB Enzymes Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 AB Enzymes Exoglucanase Product Portfolio
  90. 6.15.5 AB Enzymes Recent Developments
7 North America by Country
  1. 7.1 North America Exoglucanase Sales by Country
  2. 7.1.1 North America Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Exoglucanase Sales by Country (2021-2026)
  4. 7.1.3 North America Exoglucanase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Exoglucanase Market Size by Country
  6. 7.2.1 North America Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Exoglucanase Market Size by Country (2021-2026)
  8. 7.2.3 North America Exoglucanase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Exoglucanase Sales by Country
  2. 8.1.1 Europe Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Exoglucanase Sales by Country (2021-2026)
  4. 8.1.3 Europe Exoglucanase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Exoglucanase Market Size by Country
  6. 8.2.1 Europe Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Exoglucanase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Exoglucanase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Exoglucanase Sales by Country
  2. 9.1.1 Asia-Pacific Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Exoglucanase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Exoglucanase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Exoglucanase Market Size by Country
  6. 9.2.1 Asia-Pacific Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Exoglucanase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Exoglucanase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Exoglucanase Sales by Country
  2. 10.1.1 South America Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Exoglucanase Sales by Country (2021-2026)
  4. 10.1.3 South America Exoglucanase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Exoglucanase Market Size by Country
  6. 10.2.1 South America Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Exoglucanase Market Size by Country (2021-2026)
  8. 10.2.3 South America Exoglucanase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Exoglucanase Sales by Country
  2. 11.1.1 Middle East and Africa Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Exoglucanase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Exoglucanase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Exoglucanase Market Size by Country
  6. 11.2.1 Middle East and Africa Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Exoglucanase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Exoglucanase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Exoglucanase Value Chain Analysis
  2. 12.1.1 Exoglucanase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Exoglucanase Production Mode & Process
  7. 12.2 Exoglucanase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Exoglucanase Distributors
  10. 12.2.3 Exoglucanase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research